[go: up one dir, main page]

PE20070176A1 - Derivados de 2-oxo-imidazol sustituidos con dihidroxialquilo en n - Google Patents

Derivados de 2-oxo-imidazol sustituidos con dihidroxialquilo en n

Info

Publication number
PE20070176A1
PE20070176A1 PE2006000816A PE2006000816A PE20070176A1 PE 20070176 A1 PE20070176 A1 PE 20070176A1 PE 2006000816 A PE2006000816 A PE 2006000816A PE 2006000816 A PE2006000816 A PE 2006000816A PE 20070176 A1 PE20070176 A1 PE 20070176A1
Authority
PE
Peru
Prior art keywords
ona
piperidin
dihydro
replaced
benzimidazol
Prior art date
Application number
PE2006000816A
Other languages
English (en)
Inventor
Masaya Hashimoto
Yoshikazu Iwasawa
Hisashi Ohta
Takeshi Sagara
Atsushi Satoh
Hiroki Sakoh
Satoshi Ozaki
Hiroshi Kawamoto
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Publication of PE20070176A1 publication Critical patent/PE20070176A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA (I), EN DONDE R ES ALQUILO(C1-C6) SUSTITUIDO POR DIHIDROXI; Cy ES UN GRUPO CARBOCICLICO ALIFATICO BI O TRICICLICO (C6-C10), OPCIONALMENTE SUSTITUIDO CON ALQUILO(C1-C4). SON PREFERIDOS: 1-(2,3-DIHIDROXIPROPIL)-3-[1-(ESPIRO[4.5]DEC-6-ILMETIL)PIPERIDIN-4-IL]-1,3-DIHIDRO-2H-BENCIMIDAZOL-2-ONA, 1-(2,3-DIHIDROXIPROPIL)-3-[1-(ESPIRO[2.5]OCT-4-ILMETIL)PIPERIDIN-4-IL]-1,3-DIHIDRO-2H-BENCIMIDAZOL-2-ONA, 1-[2-HIDROXI-1-(HIDROXIMETIL)ETIL]-3-[1-(ESPIRO[BICICLO-[2.2.1]HEPTANO-2,1'-CICLOPROPAN]-3-ILMETIL)PIPERIDIN-4-IL]-1,3-DIHIDRO-2H-BENCIMIDAZOL-2-ONA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS SON ANTAGONISTAS DEL RECEPTOR DE NOCICEPTINA ORL1 (RECEPTOR TIPO OPIOIDE-1) Y SON UTILES COMO AGENTES PARA ALIVIAR LA TOLERANCIA A ANALGESICOS NARCOTICOS REPRESENTADOS POR MORFINA, POTENCIADORES DE ANALGESIA, OBESIDAD, DIABETES INSIPIDA, PILIURIA, PARKINSON
PE2006000816A 2005-07-13 2006-07-10 Derivados de 2-oxo-imidazol sustituidos con dihidroxialquilo en n PE20070176A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005204264 2005-07-13

Publications (1)

Publication Number Publication Date
PE20070176A1 true PE20070176A1 (es) 2007-03-09

Family

ID=37637260

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000816A PE20070176A1 (es) 2005-07-13 2006-07-10 Derivados de 2-oxo-imidazol sustituidos con dihidroxialquilo en n

Country Status (23)

Country Link
EP (1) EP1914232B1 (es)
JP (1) JP4748162B2 (es)
KR (1) KR20080033262A (es)
CN (1) CN101223158B (es)
AR (1) AR054816A1 (es)
AU (1) AU2006267391B2 (es)
BR (1) BRPI0613109A2 (es)
CA (1) CA2614688A1 (es)
CR (1) CR9692A (es)
DE (1) DE602006018950D1 (es)
DO (1) DOP2006000165A (es)
EC (1) ECSP088096A (es)
ES (1) ES2355580T3 (es)
IL (1) IL188418A0 (es)
MA (1) MA29738B1 (es)
NI (1) NI200800003A (es)
NO (1) NO20080770L (es)
NZ (1) NZ565026A (es)
PE (1) PE20070176A1 (es)
RU (1) RU2414456C2 (es)
TW (1) TW200740436A (es)
WO (1) WO2007007890A1 (es)
ZA (1) ZA200711025B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008297524A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of Thymopentin as a therapeutic agent
WO2009033780A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of growth hormone-releasing factor and/or k237 as a therapeutic agents
US8809397B2 (en) 2010-05-27 2014-08-19 Targacept, Inc. Nicotinic receptor non-competitive antagonists
CN108349981B (zh) * 2015-09-01 2021-03-30 大鹏药品工业株式会社 新型的吡唑并[3，4－d]嘧啶化合物或其盐
JP2024523683A (ja) * 2021-07-14 2024-06-28 イーチャン・ヒューマンウェル・ファーマシューティカル・カンパニー・リミテッド ピペリジン誘導体及びその医薬組成物、調製方法と使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU701127B2 (en) * 1994-10-27 1999-01-21 Merck & Co., Inc. Muscarine antagonists
WO1997040035A1 (en) * 1996-04-19 1997-10-30 Neurosearch A/S 1-(4-piperidyl)-benzimidazoles having neurotrophic activity
US6258825B1 (en) * 1997-05-30 2001-07-10 Banyu Pharmaceutical Co., Ltd. 2-oxoimidazole derivatives
DK1049689T3 (da) * 1998-01-19 2002-07-22 Pfizer 4-(2-keto-1-benzimidazolinyl)piperidinderivater som ORL1-receptoragonister
ID29137A (id) * 1998-07-27 2001-08-02 Schering Corp Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
ATE302770T1 (de) * 1999-12-06 2005-09-15 Euro Celtique Sa Benzimidazolverbindungen die nociceptinrezeptoraffinität haben
RU2265018C2 (ru) * 2001-04-18 2005-11-27 Эро-Селтик, С.А. Производные бензимидазола и фармацевтические композиции на их основе

Also Published As

Publication number Publication date
ES2355580T3 (es) 2011-03-29
RU2414456C2 (ru) 2011-03-20
RU2008105396A (ru) 2009-08-20
CA2614688A1 (en) 2007-01-18
AU2006267391A1 (en) 2007-01-18
CR9692A (es) 2008-02-21
NZ565026A (en) 2010-09-30
IL188418A0 (en) 2008-11-03
JP4748162B2 (ja) 2011-08-17
EP1914232A1 (en) 2008-04-23
DOP2006000165A (es) 2007-02-28
AU2006267391B2 (en) 2011-12-08
MA29738B1 (fr) 2008-09-01
ECSP088096A (es) 2008-02-20
JPWO2007007890A1 (ja) 2009-01-29
WO2007007890A1 (ja) 2007-01-18
CN101223158A (zh) 2008-07-16
AR054816A1 (es) 2007-07-18
EP1914232B1 (en) 2010-12-15
KR20080033262A (ko) 2008-04-16
ZA200711025B (en) 2008-12-31
CN101223158B (zh) 2013-01-09
BRPI0613109A2 (pt) 2012-12-04
DE602006018950D1 (de) 2011-01-27
NO20080770L (no) 2008-04-11
TW200740436A (en) 2007-11-01
EP1914232A4 (en) 2009-10-28
NI200800003A (es) 2008-07-21

Similar Documents

Publication Publication Date Title
PE20071311A1 (es) Compuestos 8-azabiciclo[3.2.1]octano como antagonistas del receptor opioide mu
EA201300869A1 (ru) Морфинановые соединения
DOP2009000232A (es) Metanoisoindoles y dionas de éstos como agentes anti-psicóticos.
BRPI0715893A2 (pt) composto de azetidina e uso para a preparaÇço de um medicamento para a prevenÇço ou tratamento de distérbios distÍmicos ou do sono
AR083831A1 (es) Antagonistas del receptor del cgrp de piperidinona carboxamida azaindano
PE20120413A1 (es) ENANTIOMERO (S) DE 1'-{[5-(TRIFLUOROMETIL)FURAN-2-IL]METIL}ESPIRO[FURO[2,3-f][1,3]BENZODIOXOL-7,3'-INDOL]-2'(1'H)-ONA
AR061564A1 (es) Derivados de isoindoles, composiciones farmaceuticas y usos
PE20091650A1 (es) Derivados de ciclohexano espirociclicos sustituidos
BRPI0514553A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos para inibir o receptor de histamina h3 em um mamìfero, para o tratamento de um distúrbio do sistema nervoso, para o tratamento de obesidade e para o tratamento de um distúrbio ou doença, e, uso de um composto ou um sal do mesmo
PE20081837A1 (es) Derivados de quinuclinidol como antagonistas de los receptores muscarinicos
BRPI0415657A (pt) derivados de alcanamina de diidrobenzofuranila como agonistas de 5ht2c
ES2337596T3 (es) Antagonistas del receptor de glucacion, preparacion y usos terapeuticaos.
PE20071023A1 (es) Azaciclilaminas-n-sustituidas como antagonistas de histamina-3
PE20081152A1 (es) Azaciclilaminas n-sustituidas como antagonistas de histamina-3
AR061015A1 (es) Compuesto y composicion farmaceutica para el tratamiento de un trastorno del sistema nervioso central relacionado con o afectado por el receptor histamina-3 y para la inhibicion del receptor h3 y proceso para la preparacion del compuesto
ATE530182T1 (de) Pharmazeutische zubereitungen enthaltend nk1- rezeptoren antagonisten und natriumkanal blockierende verbindungen
AR069607A1 (es) Inhibidores de la estearoil-coa desaturasa
PE20121556A1 (es) 3,6-diazabiciclo[3.1.1]heptanos como ligandos de receptores nicotinicos neuronales de acetilcolina
PE20050231A1 (es) Derivados de piperidinium y pirrolidinium como antagonistas del receptor muscarinico m3
CO6430439A2 (es) Agonistas del receptor de esfingosina -1- fosfato
CL2011000533A1 (es) Compuestos derivados de isoquinolina sustituida; antagonista nk3; composicion farmaceutica que lo comprende; y uso en el tratamiento de enfermedades tales como psicosis, esquizofrenia, alzheimer, parkinson, entre otras.
PE20070176A1 (es) Derivados de 2-oxo-imidazol sustituidos con dihidroxialquilo en n
AR064198A1 (es) Piperidinilamino piridazinas como antagonistas del receptor de dopamina 2 de rapida disociacion. procesos de obtencion y composiciones farmaceuticas
UY29197A1 (es) Compuestos de n-sulfonilaminobencil-2-fenoxiacetamida sustituidos
CO6300937A2 (es) Derivados de 3-carboxipropil-aminotetralina y compuestos relacionados como antagonistas de receptores opioides mu

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed